Everlab Raises AU$65m Series A to Make World-Class Preventative Healthcare Something Everyone Can Access
Australian healthtech Everlab has raised AU$65m in Series A funding. The oversubscribed round was led by Airtree Ventures (AU), with participation from global investors including Plural (EU) and existing investors Left Lane Capital (US) and b2venture (EU), alongside angel investors including Australian Test captain Pat Cummins.
Everlab Raises US$10M Seed Round to Deliver Scalable, AI-Powered Preventive Healthcare
Everlab, the AI-powered health platform reimagining preventive care, today announced a US$10 million (AU$15 million) seed round led by global growth equity firm Left Lane Capital. The funding will accelerate Everlab’s international expansion, fuel the development of its proprietary AI healthtech platform, and support the rollout of a deeply integrated product ecosystem designed to deliver lifelong, proactive care.
